Clinical trial
The Oral Cavity as a Source of Febrile Neutropenia: An Observational Study in Cancer Patients Treated With Myelosuppressive Chemotherapy
NCT02702583 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Oral Cavity as a Source of Febrile Neutropenia: An Observational Study in Cancer Patients Treated With Myelosuppressive Chemotherapy
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- January 31, 2021
- Enrollment
- 94 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dental infection, febrile neutropenia, oral infection, solid tumors